Concepedia

Brendon Frank

BF

Statistics

Publications

9

Citations

436

H-Index

9

Active since

2001

Affiliations

Amgen (United States)(Current)

University of California, San Francisco

Amgen (Germany)

Cardiovascular Institute Hospital

Brendon Frank is an author at Amgen (United States) specializing in life sciences, oncology, and signal transduction.

Publications per year

2001–2020

9

Publications

9

Mast Cell Tissue Inhibitor of Metalloproteinase-1 Is Cleaved and Inactivated Extracellularly by α-Chymase

Brendon Frank, J. Caleb Rossall, George H. Caughey et al. · The Journal of Immunology · 2001 · 88 citations

, , +12

Sphingosine Kinase Activity Is Not Required for Tumor Cell Viability

Karen Rex, Shawn Jeffries, Matthew L. Brown et al. · PLoS ONE · 2013 · 65 citations · Full text

, , +15

Tumor Necrosis Factor-α-converting Enzyme Controls Surface Expression of c-Kit and Survival of Embryonic Stem Cell-derived Mast Cells

Anthony Cruz, Brendon Frank, Samuel Edwards et al. · Journal of Biological Chemistry · 2004 · 62 citations · Full text

, , +13

Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents

Hilary P. Beck, Todd J. Kohn, Steven M. Rubenstein et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 55 citations · Full text

, , +10

Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid Leukemia

Bettina Brauchle, Rebecca Goldstein, Christine M. Karbowski et al. · Molecular Cancer Therapeutics · 2020 · 54 citations · Full text

, , +17

1–5 of 9